Company: SCLXW
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0000950170-25-007391
Chunk: 4

Company: Scilex Holding Co
Filing Date: 2025-01-21
Form: 424B3
Chunk 4
---
The Company filed its Form 10-Q on January 17, 2025.

On January 21, 2025, the Company issued (i) a press release announcing its filing of the Form 10-Q and (ii) a press release announcing that it had regained compliance with the Listing Rule. A copy of each press release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

| Exhibit Number 
 99.1           
 99.2           | Description                                                                                           
 Press Release issued by Scilex Holding Company on January 21, 2025.                                   
 Press Release issued by Scilex Holding Company on January 21, 2025.                                   |
|:---------------|:------------------------------------------------------------------------------------------------------|
| 104            | Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). |

<div align='center'>2

SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

|                        | SCILEX HOLDING COMPANY |                                       |
|                        | By:                    | /s/ Jaisim Shah                       |
|                        | Name:                  | Jaisim Shah                           |
| Date: January 21, 2025 | Title:                 | Chief Executive Officer and President |

<div align='center'>3</div>

Exhibit 99.1

FOR IMMEDIATE RELEASE

January 21, 2025

Scilex Holding Company Announces Filing of its Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2024

PALO ALTO, CALIFORNIA – January 21, 2025 (GLOBE NEWSWIRE) -Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 and expects to receive notification from The Nasdaq